20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Clinical Evaluation of Tiopronin: Insights from Research Studies

NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting the pharmaceutical industry with high-quality intermediates like Tiopronin. The clinical effectiveness and application of such compounds are constantly being refined through rigorous research. This article explores key insights from clinical studies involving Tiopronin.

Tiopronin has been clinically evaluated for several key applications. In the treatment of cystinuria, a genetic disorder affecting cystine excretion, Tiopronin is a recognized prescription drug. Its ability to decrease cystine precipitation in the kidneys is well-documented and forms the basis of its use in managing this condition. As an orphan drug, its importance for patients with rare diseases is significant.

Another major area of clinical investigation is Tiopronin's role in managing liver conditions, such as fatty liver disease and drug-induced liver injury. Studies have demonstrated that Tiopronin can improve liver function by reducing elevated liver enzymes and other biochemical markers. Its antioxidant properties are believed to be central to these protective effects, making it a valuable agent for patients experiencing liver stress from various causes, including certain medical treatments.

Recent research has also focused on Tiopronin's efficacy as a prophylactic agent, particularly in preventing hepatotoxicity in patients undergoing gynecological cancer treatments. While studies suggest Tiopronin can be beneficial, some investigations indicate that simply prolonging the duration of its administration might not significantly enhance its protective effects. This highlights the need for nuanced understanding and personalized application of the drug.

For institutions and researchers looking to purchase Tiopronin, these clinical insights are invaluable. NINGBO INNO PHARMCHEM CO.,LTD. provides high-grade Tiopronin to support ongoing clinical research and pharmaceutical development, ensuring that reliable intermediates are available for advancing patient care.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Chemical Properties and Therapeutic Mechanisms of Tiopronin

Next: Procuring Quality Tiopronin: Factors for Buyers and Manufacturers

All Rights Reserved